SAN FRANCISCO, Oct. 29 – Qiagen on Monday reported a 14 percent drop in operating profits, which it said was a result of the Sept. 11 terrorist attacks on the United States.

The company saw a “significant rebound in sales beginning in early October” and expects continued strong growth in its sector, it said in a statement.

Earnings before interest and tax fell to $10.1 million from $11.8 million recorded in the same period one year ago, and net profit dipped to $6.2 million from $7.2 million, Qiagen said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.